Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,850 | 47,987 | 32,908 | 11,534 | 6,890 |
| Marketable Securities | N/A | N/A | 2,678 | N/A | 0 |
| Receivables | N/A | 3,683 | N/A | N/A | 0 |
| Inventories | N/A | 386 | N/A | N/A | 0 |
| Other current assets | 27,013 | 0 | 0 | 0 | 150 |
| TOTAL | $52,100 | $53,455 | $36,121 | $11,810 | $7,040 |
| Non-Current Assets | |||||
| PPE Net | 285 | 665 | 29 | 393 | 410 |
| Intangibles | 15,152 | 20,877 | 5,898 | 5,898 | 0 |
| Other Non-Current Assets | 12,951 | 12,979 | 12,938 | 12,867 | 10 |
| TOTAL | $28,388 | $34,521 | $18,865 | $19,158 | $420 |
| Total Assets | $80,488 | $87,976 | $54,986 | $30,968 | $7,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,910 | 2,149 | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 1,886 | 2,660 | 1,976 | 2,155 | 720 |
| Accrued Expenses | 8,885 | 8,699 | 2,038 | 2,168 | 740 |
| Other current liabilities | 5,383 | 48,965 | 11,899 | 5,528 | 3,510 |
| TOTAL | $27,233 | $62,473 | $15,919 | $11,202 | $5,020 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,492 | 7,743 | N/A | N/A | 0 |
| Deferred Revenues | N/A | N/A | N/A | 816 | N/A |
| Other Non-Current Liabilities | 6,651 | 6,821 | 6,207 | 4,569 | 0 |
| TOTAL | $16,196 | $19,617 | $11,311 | $9,654 | $20 |
| Total Liabilities | $43,429 | $82,090 | $27,230 | $20,856 | $5,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 4 | 3 | N/A | 1 |
| Common Shares | 12 | 10 | 8 | 5 | 2 |
| Retained earnings | -215,481 | -178,875 | -102,197 | -67,228 | -55,740 |
| Other shareholders' equity | 151 | 151 | 1,777 | 151 | 148 |
| TOTAL | $37,059 | $5,886 | $27,756 | $10,112 | $2,430 |
| Total Liabilities And Equity | $80,488 | $87,976 | $54,986 | $30,968 | $7,470 |